Declaring that it is "determined to grow its portfolio in the complex generics space," Novartis generics division Sandoz announced its acquisition of device device developer Coalesce Product Development. Coalesce's inhaler technology include MDI, breath-actuated MDI, and DPI platforms. Sandoz said that it "sees respiratory as a key pillar of its ambitious long-term … [Read more...] about Sandoz acquires inhaler developer Coalesce Product Development
Products and Services
Adherium submits 510(k) for Hailie sensor to be used with Ellipta DPIs
Inhaler monitoring company Adherium has announced the submission of a 510(k) for a new Hailie sensor designed specifically for use with Ellipta DPIs. In September 2021, the FDA cleared another version of the next generation Hailie sensor for use with Symbicort MDIs. The sensors, which snap on to the outside of the device, connect to a cloud-based monitoring platform … [Read more...] about Adherium submits 510(k) for Hailie sensor to be used with Ellipta DPIs
HCmed, Formosa Laboratories, and Formosa Pharmaceuticals partner on new inhalation CDMO
Device maker HCmed Innovations has partnered with Formosa Laboratories and Formosa Pharmaceuticals to offer contract development and manufacturing services for inhaled drugs, HCmed announced. Formosa Laboratories already offers CDMO services for pharmaceutical products; the new services will also incorporate Formosa Pharmaceutical's nanotechnology platform and HCmed's … [Read more...] about HCmed, Formosa Laboratories, and Formosa Pharmaceuticals partner on new inhalation CDMO
Broughton launches US subsidiary
Broughton, a CRO that offers development and analysis of inhaled drugs, especially nicotine and cannabinoid products, has announced the establishment of a US subsidiary. Tony Jones, who has most recently been Senior Managing Health Scientist at consulting firm Cardno Chemrisk, was named Managing Consultant of the new business. Jones commented, "I am delighted to be … [Read more...] about Broughton launches US subsidiary
TFF Pharmaceuticals partners with Catalent for DPI development and manufacturing
TFF Pharmaceuticals has partnered with CDMO Catalent for scale-up and manufacturing of dry powder formulations based on TFF's thin film freezing technology the companies have announced. The partnership will make the TFF technology available to other Catalent clients as well. Catalent notes that the TFF technology is its second addition to its inhaled dry powder … [Read more...] about TFF Pharmaceuticals partners with Catalent for DPI development and manufacturing
Kindeva announces second lower-GWP MDI manufacturing line
CDMO Kindeva Drug Delivery has announced that it will invest in a second MDI manufacturing line capable of filling lower global warming potential (GWP) propellants such as HFA 152a and HFO 1234ze in response to increasing demand. The company announced plans to install its first lower-GWP propellant filling line in November 2021. The new line is expected to be … [Read more...] about Kindeva announces second lower-GWP MDI manufacturing line
AstraZeneca partners with Honeywell on development of HFO-1234ze MDIs
AstraZeneca has announced a partnership with Honeywell for development of lower global warming potential MDIs using HFO-1234ze as a propellant. The company said that Breztri budesonide/ glycopyrronium/ formoterol fumarate is the first product it plans to convert to HFO-1234ze and that a Phase 1 trial of an HFO 1234ze formulation of budesonide/ glycopyrronium/ … [Read more...] about AstraZeneca partners with Honeywell on development of HFO-1234ze MDIs
Aptar Pharma breaks ground on new manufacturing facility in Mumbai
OINDP device manufacturer Aptar Pharma recently broke ground on new manufacturing facility on a 3.5 acre site in Mumbai, India, with the groundbreaking taking place on the tenth anniversary of the existing Aptar facility in Mumbai, the company said. Construction on the new facility is expected to be complete by the first quarter of 2023. The existing facility, … [Read more...] about Aptar Pharma breaks ground on new manufacturing facility in Mumbai
Aptar Pharma launches HeroTracker Sense MDI sensor
Aptar Pharma announced that it has launched a metered dose inhaler add-on sensor called HeroTracker Sense. According to Aptar, the device has been CE marked and is "pending FDA approval." HeroTracker inhaler sensors were originally developed by Cohero Health, which was acquired by Aptar in 2020. The company says that HeroTracker Sense, which snaps onto the MDI … [Read more...] about Aptar Pharma launches HeroTracker Sense MDI sensor
RxPack to distribute Biocorp’s Inspair inhaler sensor in certain territories
Biocorp and RxPack have announced a new distribution agreement giving RxPack the exclusive rights to commercialize Biocorp's Inspair inhaler sensor in Eastern Europe, Southeast Asia, South America, and the Middle East. Lindal had obtained the rights to market Inspair in those territories in 2018, and RxPack is a joint venture of Lindal and Coster which was formed in … [Read more...] about RxPack to distribute Biocorp’s Inspair inhaler sensor in certain territories